Animal-free cell growth solutions for the future of biotech
Booster is Cellivate's Extra-cellular Vesicle (EV)-based alternative to FBS, designed to improve cell growth, consistency, and sustainability across advanced cell culture applications.
Fetal Bovine Serum (FBS) needs to be replaced
🔴 Ethically Compromised
Extracted from the blood of cow fetus obtained during slaughter
🔴 Extreme Lot Variability
Compositions fluctuate dramatically between batches, ruining experiment reproducibility.
🔴 Supply-Constrained & Costly
Global supply constraints keep costs prohibitively high and growing, with no relief in sight.
Critical Bottlenecks in FBS Utilization
FBS Sourcing Reality
Representative image of animal fetuses used for blood draw.
Cross-Contamination Risk
Animal-derived serums bring inherent biological risks, including viruses, mycoplasma, and prions, complicating clinical regulatory pathways.
Batch-to-Batch Variability
Serum compositions fluctuate dramatically between lots, ruining reproducibility in academic and industrial labs.
Major Driver of COGS
Accounting for up to 90% of operating expenditures in cell cultivation, the cost volatility of serum restricts biomanufacturing scale.
Product Formulation
BOOSTER
EVs based on custom cells. Recommended for primary cell based workflows and biomanufacturing.
Apply for a Sample KitProven results.
Across multiple cell types.
Extensive in-house testing shows Booster consistently enhances cell growth and viability compared to FBS.
Cell Growth Comparison
Up to 60% improvement compared to FBS
